All Articles

Holiday spending pushed credit balances to a new high, but a sharp rise in delinquencies signals a K-shaped economy where many face a financial reckoning.

In a landmark deal, BioMarin acquires Amicus Therapeutics, gaining high-growth drugs and reshaping the landscape for patients with rare genetic disorders.

Loyola Marymount University is expanding its EV charging with ChargePoint's AI platform and maintenance service, creating a reliable network for its community.

A landmark executive order reclassifying cannabis is set to unleash a wave of biopharma innovation, validating science-first firms like Avicanna.

Aduro Clean Technologies raises $20M for a key plant, navigating market jitters to fund its game-changing chemical recycling technology.

The latest VyOS release adds TLS for syslog, AWS GWLB support, and RPKI controls, boosting security and flexibility for modern network infrastructures.

A strategic partnership aims to merge respiratory rentals with innovative hygiene products, promising better compliance and comfort for millions of CPAP users.

A trio of real estate giants will build a massive rental complex in Vieux-Longueuil, a major move to address the South Shore's critical housing shortage.

The powerboat giant expands its share repurchase in a show of financial strength, betting on long-term recovery despite a soft recreational market.

In a high-level diplomatic dinner, Argentina's ambassador showcased President Milei's sweeping reforms, signaling a new chapter for UK investment.

A cancer research firm is betting its future on Zcash, recruiting the crypto's top minds. Is this the start of institutional adoption for privacy coins?

Alvotech and Teva's settlement with Regeneron for an Eylea biosimilar paves the way for a 2026 launch, promising increased competition and lower costs.

Danish water tech firm Aquaporin seeks urgent funding, warning of 77% dilution for shareholders as it races to secure its future and new technology.

Facing a cash crunch, the Danish innovator seeks funds to survive, betting its future on a next-gen biotech solution to global water challenges.

A new settlement positions a cost-effective alternative to the blockbuster eye drug Eylea for a 2026 U.S. launch, signaling intense market disruption.

A new joint venture aims to redefine Tallinn's skyline with a potential 60-storey high-rise, part of a major expansion in the Manufaktuuri quarter.

The CEO of Genenta Science now owns 10% of the company, all bought on the open market. What does this bold insider move signal for its cancer therapy?

A new partnership between power module expert SOLUM and charger innovator i-charging aims to supercharge e-mobility with next-gen tech and a human-centric vision.

CLO Virtual Fashion launches a Dongguan hub, integrating its massive digital fabric library to transform the global apparel supply chain from the source.

The VCT posts a marginal loss but shows second-half recovery, while navigating strategic exits and facing a pivotal shift in UK VCT tax policy.